March-in Rights

C4IP Letter RE: 5/21 Hearing on Drug Prices, 5/20/2024

June 12, 2024 No Comments

Op-ed: Judge Paul Michel, “Biden’s shortsighted patent attacks threaten American innovation,” The Hill, 6/4/2024

June 4, 2024 No Comments

C4IP Comments RE: Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace, 5/13/2024

May 13, 2024 No Comments

Op-ed: Dana Colarulli, “President Biden, Don’t Undo Your Innovation Legacy,” RealClearHealth, 5/2/2024

May 2, 2024 No Comments

Issue Brief: The Bayh-Dole Act and March-In Rights, December 2023

April 9, 2024 No Comments

What IP Experts Are Saying About the Biden Administration’s Draft Framework for March-In Rights, February 2024

April 9, 2024 No Comments

Blog: Fact Check: Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices, 1/29/2024

April 9, 2024 No Comments

Briefing: The Bayh-Dole Act and March-In Rights, 1/24/2024

April 9, 2024 No Comments

Blog: Fact Check: The Bayh-Dole Act Does Not Impede Knowledge Sharing, 6/16/2023

April 9, 2024 No Comments

Op-ed: Andrei Iancu and David Kappos, “New Yorkers should be concerned about Biden proposal on academic research,” The Buffalo News, 4/8/2024

April 8, 2024 No Comments

Op-ed: Amir Naiberg and Andrei Iancu, “Biden administration proposal threatens innovative research at universities across the country,” The Orange County Register, 4/1/2024

April 1, 2024 No Comments

Op-ed: Andrei Iancu and David Kappos, “‘March-in’ rights: Why Biden’s changes contradict the point of the Bayh-Dole Act,” World IP Review, 2/15/2024

February 15, 2024 No Comments

C4IP Letter RE: 5/21 Hearing on Drug Prices, 5/20/2024

June 12, 2024

Op-ed: Judge Paul Michel, “Biden’s shortsighted patent attacks threaten American innovation,” The Hill, 6/4/2024

June 4, 2024

C4IP Comments RE: Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace, 5/13/2024

May 13, 2024

Op-ed: Dana Colarulli, “President Biden, Don’t Undo Your Innovation Legacy,” RealClearHealth, 5/2/2024

May 2, 2024

Issue Brief: The Bayh-Dole Act and March-In Rights, December 2023

April 9, 2024

What IP Experts Are Saying About the Biden Administration’s Draft Framework for March-In Rights, February 2024

April 9, 2024

Blog: Fact Check: Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices, 1/29/2024

April 9, 2024

Briefing: The Bayh-Dole Act and March-In Rights, 1/24/2024

April 9, 2024

Blog: Fact Check: The Bayh-Dole Act Does Not Impede Knowledge Sharing, 6/16/2023

April 9, 2024

Op-ed: Andrei Iancu and David Kappos, “New Yorkers should be concerned about Biden proposal on academic research,” The Buffalo News, 4/8/2024

April 8, 2024

Op-ed: Amir Naiberg and Andrei Iancu, “Biden administration proposal threatens innovative research at universities across the country,” The Orange County Register, 4/1/2024

April 1, 2024

Op-ed: Andrei Iancu and David Kappos, “‘March-in’ rights: Why Biden’s changes contradict the point of the Bayh-Dole Act,” World IP Review, 2/15/2024

February 15, 2024

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

March-in Rights

C4IP Letter RE: 5/21 Hearing on Drug Prices, 5/20/2024

Op-ed: Judge Paul Michel, “Biden’s shortsighted patent attacks threaten American innovation,” The Hill, 6/4/2024

C4IP Comments RE: Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace, 5/13/2024

Op-ed: Dana Colarulli, “President Biden, Don’t Undo Your Innovation Legacy,” RealClearHealth, 5/2/2024

Issue Brief: The Bayh-Dole Act and March-In Rights, December 2023

What IP Experts Are Saying About the Biden Administration’s Draft Framework for March-In Rights, February 2024

Blog: Fact Check: Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices, 1/29/2024

Briefing: The Bayh-Dole Act and March-In Rights, 1/24/2024

Blog: Fact Check: The Bayh-Dole Act Does Not Impede Knowledge Sharing, 6/16/2023

Op-ed: Andrei Iancu and David Kappos, “New Yorkers should be concerned about Biden proposal on academic research,” The Buffalo News, 4/8/2024

Op-ed: Amir Naiberg and Andrei Iancu, “Biden administration proposal threatens innovative research at universities across the country,” The Orange County Register, 4/1/2024

Op-ed: Andrei Iancu and David Kappos, “‘March-in’ rights: Why Biden’s changes contradict the point of the Bayh-Dole Act,” World IP Review, 2/15/2024

C4IP Letter RE: 5/21 Hearing on Drug Prices, 5/20/2024

Op-ed: Judge Paul Michel, “Biden’s shortsighted patent attacks threaten American innovation,” The Hill, 6/4/2024

C4IP Comments RE: Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace, 5/13/2024

Op-ed: Dana Colarulli, “President Biden, Don’t Undo Your Innovation Legacy,” RealClearHealth, 5/2/2024

Issue Brief: The Bayh-Dole Act and March-In Rights, December 2023

What IP Experts Are Saying About the Biden Administration’s Draft Framework for March-In Rights, February 2024

Blog: Fact Check: Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices, 1/29/2024

Briefing: The Bayh-Dole Act and March-In Rights, 1/24/2024

Blog: Fact Check: The Bayh-Dole Act Does Not Impede Knowledge Sharing, 6/16/2023

Op-ed: Andrei Iancu and David Kappos, “New Yorkers should be concerned about Biden proposal on academic research,” The Buffalo News, 4/8/2024

Op-ed: Amir Naiberg and Andrei Iancu, “Biden administration proposal threatens innovative research at universities across the country,” The Orange County Register, 4/1/2024

Op-ed: Andrei Iancu and David Kappos, “‘March-in’ rights: Why Biden’s changes contradict the point of the Bayh-Dole Act,” World IP Review, 2/15/2024

Contact

Menu